In this prospective-retrospective, multi-institutional study we investigated disparity in four pro-metastatic TME parameters in residual disease post-NAC according to breast cancer subtype (ER+/HER- vs TNBC) and race (Black vs white patients), as well as the association of high density of these parameters with DRFS in all patients. Here, ESR1 is linked to breast cancer.